CBIS Stock UPDATES Cannabis Science Inc (CBIS) 0.0770 08/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cannabis Science Inc (CBIS) 0.0770 $CBIS

Cannabis Science Initiates Pre-Clinical Studies on Cannabinoid Formulations in Neurological Diseases Including Sleep Disorders with the Highly Reputable Institute for Health and Science on Ageing - INRCA - in Italy
PR Newswire Europe - Mon Aug 04, 8:25AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is announcing that through its wholly-owned subsidiary, Cannabis Science International Holding BV, has signed an agreement with the prestigious Institute for Research, Hospitalization and Health Care on Ageing (INRCA) in Italy. The agreement provides for toxicity and efficacy studies of cannabinoid formulations performed in animal models for neurobehavioral diseases including sleep disorders.

Dr. Robert Melamede Joins Cannabis Professional University in Charlotte, NC at Business Seminar
PRWeb - Mon Aug 04, 5:37AM CDT
Cannabis Professional University announces that world-renowned medical cannabis research expert Dr. Robert Melamede, a Ph.D. in Molecular Biology and Biochemistry, has been added to the list of speakers at the Cannabis Business Seminar in Charlotte, North Carolina on Sunday August 3 from 9 am until 5 pm at the Sheraton Charlotte Airport Hotel.

Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders
PR Newswire - Thu Jul 31, 10:07AM CDT
Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce that it has commenced production of multiple strains of cannabis and European Union certified hemp varieties to initiate scientific research to select the best strains for development of proprietary formulations for clinical drug development to bring the cannabis formulations to market for critical ailments such as cancer and neurological disorders.

CBIS Very Excited Over Federal Cannabis Legalization Efforts in U.S. House and Senate to Change Medical Cannabis Laws
PR Newswire - Wed Jul 30, 6:30AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is extremely excited to report federal cannabis legalization efforts in U.S. House and Senate to change medical cannabis laws across the country. This can be a major game changer for Cannabis Science's efforts to commence its cannabis treatments nationwide for a number of targeted critical ailments.

Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change
PR Newswire - Tue Jul 29, 8:20AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, applauds the Editorial Board of the New York Times for taking a strong position in opposition to current federal law on cannabis in its Sunday, July 27, 2014 publication. The New York Times also announces a series of upcoming editorials and articles this week exploring the issue called "High Time: An Editorial Series on Marijuana Legalization".

Legal Medical Marijuana Industry Goes Through Significant Changes as Progressive Regulatory Developments are Implemented - Company Aims to Take Advantage of Latest Developments
PR Newswire - Thu Jul 24, 12:10PM CDT
Cannabis and Legal Medical Marijuana companies adapt to latest industry developments with innovative operations and products to meet evolving expectations of both consumers and government regulations: OSL Holdings (OTC: OSLH), Hemp, Inc. (OTC: HEMP), FutureWorld Corp. (OTC: FWDG), Cannabis Science, Inc. (OTC: CBIS) and Terra Tech Corp. (OTC: TRTC)

Flagship Financial Year for Cannabis Science (CBIS:OTC.QB) Arrives Amid New Medical Marijuana Legislation
ACCESSWIRE - Thu Jul 24, 7:34AM CDT
BOCA RATON, FL / ACCESSWIRE / July 24, 2014 / In the fast growing small cap market of medical marijuana companies we believe Cannabis Science stands out among its peers such as American Green (ERBB: OTC.PK), Medical Marijuana, Inc (MJNA:OTC.PK), Hemp, Inc (HEMP:OTC.PK) and Abattis Bioceuticals Corp (ATTBF:OTC.QX)

Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company
PR Newswire - Thu Jul 24, 6:56AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is pleased to announce the appointment of Dr. Roscoe M. Moore, Jr., formerly the US Assistant Surgeon General, for a second term on the scientific advisory board and as a special Senior Advisor to the Company. Among other contributions, Dr. Moore will be leading the Cannabis Science initiative in Africa.

NTRR: Cannabis Demand in California Could Top $2.1 Trillion
Business Wire - Tue Jul 22, 5:46AM CDT
Even as the state of Washington became the second to begin allowing recreational cannabis sales last week, Neutra Corp. (OTCBB: NTRR) and other business ancillary to the cannabis marketplace are already eying the potential for even larger marketplaces to the south. SF Weekly reported last week that demand for recreational cannabis in California could top an astounding $2.1 trillion.

CFO Journal, part of the Wall Street Journal, addresses business challenges of cannabis industry in the article "Pot Industry Puts on a Tie" referencing Cannabis Science, Inc. (CBIS) Chief Financial Officer, Robert Kane
PR Newswire - Fri Jul 18, 12:40PM CDT
Cannabis Science, Inc. (OTC:CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting bring attention to more evidence on the investor appetite to invest in quality companies.

Cannabis Capital Corp. (CBCA) Changes Name to Crown Baus Capital Corp., Better Reflecting Corporate Initiatives and Long-term Projects
PR Newswire - Thu Jul 17, 7:16AM CDT
Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is pleased to announce that its Board of Directors has selected the name Crown Baus Capital Corp. to better reflect the company's existing and prospective ventures in these five business sectors. Simultaneous with this announcement of the corporate name change, the Company's website www.crownbaus.com has been launched.

NTRR Orders First Production Run of New Product Offering
Business Wire - Thu Jul 17, 4:00AM CDT
In preparation for the release of its new Diamond Anvil Vapor Pen, Neutra Corp. (OTCBB: NTRR) has ordered the first production run of the new product offering from its manufacturer.

New Markets Open up for NTRR Products
Business Wire - Thu Jul 10, 6:30AM CDT
As Neutra Corp. (OTCBB: NTRR) and its joint venture partners work to create innovative new indoor horticulture solutions, an enormous market for medical cannabis cultivation appears to be opening up in Canada.

Cannabis Science, Inc. (CBIS) Prepares for New York State as it becomes the 23rd state to authorize Medical Marijuana use
PR Newswire - Tue Jul 08, 8:41AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting applauds the legalization of medical marijuana usage in New York State opening the opportunity to help one of the largest US populations of patients with legal medical cannabis.

NTRR Scouts Opportunities in Underserved Cannabis Financial Services Sector
Business Wire - Tue Jul 08, 4:00AM CDT
With cannabis sales spreading across the country thanks to growing legalization and regulation of the herb, Neutra Corp. (OTCBB: NTRR) is investigating new opportunities arising in the fledgling industry's financial services sector.

NTRR: Loosening Regulations Send Investors Flocking to Cannabis Industry
Business Wire - Thu Jul 03, 7:45AM CDT
As Neutra Corp. (OTCBB: NTRR) prepares to deliver new horticultural innovations to market, a new wave of investment capital is flooding into the U.S. cannabis industry.

NTRR: New York Joins Rapidly Growing U.S. Cannabis Market
Business Wire - Tue Jul 01, 4:00AM CDT
As Neutra Corp. (OTCBB: NTRR) prepares for the release of its cutting-edge Diamond Anvil vaporizer pen next month, New York has become the 23rd state to legalize medical marijuana.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

GFI Software Celebrates Partner Excellence with 2025 Awards

Updated Category News Views 259

GFI Software Celebrates Partner Excellence with 2025 Awards GFI Software, a leader in AI-driven security and communications solutions tailored for small and medium-sized businesses, has announced its 2025 Partner Award winners. With a strong commitment to enhancing customer relationships through a dedicated partner network, GFI Software recognizes those partners who have...

Continue Reading
Join the Class Action Against Fly-E Group, Inc. Today!

Updated Category News Views 176

Important Class Action Alert for Fly-E Group, Inc. Attention investors in Fly-E Group, Inc. (NASDAQ: FLYE). There is a significant class action lawsuit that may impact your investments. If you were affected by the company's actions during the outlined period, it's crucial to know how to proceed. Understanding the context and ramifications of this lawsuit could be...

Continue Reading
Canada's Largest Clean Energy Conference Highlights Innovation

Updated Category News Views 318

Canada's Leading Clean Energy Conference Unveils Future Vision More than 2,600 attendees gathered at the largest clean energy conference and exhibition in Canada, showcasing the commitment of industry experts towards a sustainable future. This event, a hallmark of the Canadian Renewable Energy Association (CanREA), illuminated the pressing issues and opportunities within...

Continue Reading
Unlocking the Secrets of Lobster with Grant MacPherson

Updated Category News Views 182

Unleashing Culinary Creativity with Lobster Grant MacPherson, a culinary wizard with an impressive history in the kitchen, has officially launched his fourth cookbook, Viva La Lobster. This charming collection features 53 creative recipes that showcase the delightful crustacean in unconventional ways, from S'mores and Frozen Pops to the traditional Lobster Bisque. Lobster...

Continue Reading
Howmet Aerospace Stock Faces Downgrade Amid Demand Concerns

Updated Category News Views 198

Understanding KeyBanc's Downgrade of Howmet Aerospace Howmet Aerospace Inc. (NYSE:HWM) recently saw a shift in its stock evaluation when KeyBanc moved its rating from Overweight to Sector Weight. This decision comes in response to a noticeable cooling in demand within the commercial aerospace industry, prompting analysts to reconsider their outlook on the company. Despite...

Continue Reading